TY  - JOUR
AU  - Garrido, Greta
AU  - Rabasa, Ailem
AU  - Garrido, Cristina
AU  - Chao, Lisset
AU  - Garrido, Federico
AU  - García-Lora, Ángel M
AU  - Sánchez-Ramírez, Belinda
PY  - 2017
DO  - 10.3389/fphar.2017.00595
SN  - 1663-9812
UR  - http://hdl.handle.net/10668/11712
T2  - Frontiers in pharmacology
AB  - Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A growing emphasis is being placed on immune regulator genes that govern tumor - T cell...
LA  - en
KW  - EGFR
KW  - HLA class I molecules
KW  - antibodies
KW  - nimotuzumab
KW  - tumor cells
TI  - Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.
TY  - research article
VL  - 8
ER  -